Frederic Harb | Biochemistry | Research Excellence Award

Research Excellence Award

Frederic Harb
University of Balamand, Lebanon

Frederic Harb
Affiliation University of Balamand
Country Lebanon
Scopus ID 55509977300
Documents 56
Citations 462
h-index 14
Subject Area Biochemistry
Event Best Paper Awards
ORCID 0000-0001-5882-1619

This academic article summarizes the scholarly profile, research activity, and scientific contributions of Frederic Harb of the University of Balamand. The article presents a concise overview of publication performance, citation indicators, research impact, and suitability for recognition through the Research Excellence Award program.[1]

Abstract

Frederic Harb is a researcher affiliated with the University of Balamand whose academic work is primarily associated with biochemistry and related biomedical investigations. Based on available bibliometric indicators, the researcher has produced 56 indexed documents, accumulated 462 citations, and achieved an h-index of 14. These metrics indicate sustained scholarly activity and measurable influence within the scientific literature. The profile demonstrates engagement in peer-reviewed research, interdisciplinary collaboration, and knowledge dissemination. This article provides a concise assessment of research achievements, publication performance, scientific impact, and relevance to the objectives of the Research Excellence Award.[1]

Keywords

Biochemistry, Research Excellence Award, Scientific Publications, Citation Impact, Academic Recognition, Scholarly Contributions, University of Balamand, Research Assessment.

Introduction

Research evaluation commonly considers publication productivity, citation influence, and scholarly engagement. Frederic Harb has developed a documented academic profile within biochemistry, contributing to scientific literature through peer-reviewed publications and collaborative investigations. Such indicators provide a foundation for assessing research quality and academic standing.[1]

Research Profile

The researcher is affiliated with the University of Balamand in Lebanon. Bibliometric records indicate 56 indexed publications, 462 citations, and an h-index of 14. These metrics reflect continuing participation in scholarly communication and demonstrate an established presence within the academic research community.[1]

Research Contributions

Research contributions have focused on biochemistry and related scientific disciplines. Published studies contribute to understanding biological mechanisms and biomedical applications. Through collaborative investigations and peer-reviewed dissemination, the researcher has supported the advancement of scientific knowledge and promoted evidence-based research practices.[2]

Publications

The publication record includes 56 indexed documents covering diverse aspects of biochemistry. These outputs have appeared in peer-reviewed scholarly venues and contribute to scientific discourse. Publication activity demonstrates consistency in research engagement and participation in internationally recognized academic communication channels.[1]

Research Impact

Citation indicators provide evidence of research visibility and scholarly influence. With 462 citations and an h-index of 14, the researcher’s work has been referenced by other academics, demonstrating relevance within the scientific community. These metrics indicate measurable impact and ongoing recognition of published findings.[1]

Award Suitability

The available academic indicators suggest suitability for consideration within research recognition programs. Publication productivity, citation performance, and demonstrated scholarly engagement align with common evaluation criteria used by academic award committees when assessing scientific achievement and contribution to disciplinary advancement.[3]

Conclusion

Frederic Harb has established a documented research profile characterized by peer-reviewed publications, citation impact, and scientific engagement. The available evidence supports recognition of sustained academic contributions and highlights the researcher’s role in advancing biochemistry-related scholarship through scholarly communication and collaborative research activities.

References

  1. Elsevier. (n.d.). Scopus author details: Frederic Harb, Author ID 55509977300. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55509977300
  2. ORCID. (n.d.). Research activities and scholarly profile of Frederic Harb.
    https://orcid.org/0000-0001-5882-1619
  3. Assessing Drug Administration Techniques in Zebrafish Models of Neurological Disease.
    https://www.mdpi.com/1422-0067/24/19/14898

  4. Mechanisms, Biomarkers, and Treatment Approaches for Diabetic Kidney Disease: Current Insights and Future Perspectives.
    https://www.mdpi.com/2077-0383/14/3/727

P. V. G. K Sarma | Biochemistry | Editorial Board Member

Assoc. Prof. Dr. P. V. G. K Sarma | Biochemistry | Editorial Board Member 

Associate Professor | Sri Venkateswara Institute of Medical Sciences | India

P. V. G. K. Sarma is a senior Indian biotechnologist and academic leader currently serving as the Head of the Department of Biotechnology at the Sri Venkateswara Institute of Medical Sciences, Tirupati, a position he has held since 2004, with his academic training from JNTU Hyderabad and a broad research portfolio reflected in over a hundred scholarly publications indexed across major journals. P. V. G. K. Sarma His core research spans genetic engineering, microbial biotechnology, functional genomics, structural bioinformatics, and stem cell differentiation with a strong translational focus on regenerative medicine and human disease. A major strength of his work lies in the in vitro differentiation of human CD34+ hematopoietic stem cells into diverse lineages including pancreatic β-cells, erythrocytes, podocytes, type-II pneumocytes, keratinocytes, chondrocytes, and megakaryocytes, contributing to the understanding of cellular plasticity and therapeutic cell generation. Parallel to this, he has made significant contributions to microbial pathogenesis, particularly on Staphylococcus aureus, elucidating molecular mechanisms of biofilm formation, metabolic regulation, and antimicrobial resistance, including MRSA, through gene expression, enzyme activity, and structure-based drug design approaches. His interdisciplinary research also addresses clinical and molecular genetics, with notable studies on mutations linked to congenital erythrocytosis, breast cancer, leukemia drug resistance, rheumatoid arthritis, tuberculosis susceptibility, cardiovascular disease, and pain genetics. During the COVID-19 period, his in silico investigations on antiviral compounds targeting SARS-CoV-2 proteins further demonstrated his adaptability across emerging biomedical challenges. He has consistently integrated wet-lab experimentation with computational biology, signaling pathways, and nanobiotechnology, including cytotoxicity studies of silver nanoparticles on human stem cells. Beyond research, he is actively involved in peer review for reputed international journals and contributes to clinical translational science through collaborations across medicine, genetics, and biotechnology. Collectively, his career reflects sustained leadership in Indian biomedical research, with impactful contributions to stem cell biology, microbial biotechnology, and molecular genetics aimed at advancing diagnostics, therapeutics, and regenerative strategies.

Profile: ORCID

Featured Publications

  1. Chandrasekhar, C., Kumar, P. S., & Sarma, P. V. G. K. (2019). Novel mutations in the kinase domain of BCR-ABL gene causing imatinib resistance in chronic myeloid leukemia patients. Scientific Reports, 9, 38672.

  2. Loganathan, S. E., Kattaru, S., Kodavala, S., Chandrasekhar, C., & Sarma, P. V. G. K. (2024). Prominent expression of COL2A1, ACAN and IHH genes observed in the differentiation of human hematopoietic stem cells into articular type of chondrocytes. Stem Cell Reviews and Reports, 20.

  3. Kodavala, S., Loganathan, S. E., Kattaru, S., Chandrasekhar, C., & Sarma, P. V. G. K. (2024). In vitro generation of epidermal keratinocytes from human CD34-positive hematopoietic stem cells. In Vitro Cellular & Developmental Biology – Animal, 60.

  4. Suthi, S., Mounika, A., & Sarma, P. V. G. K. (2023). Elevated acetate kinase (ackA) gene expression, activity, and biofilm formation observed in methicillin-resistant strains of Staphylococcus aureus. Journal of Genetic Engineering and Biotechnology, 21.

  5. Kattaru, S., Manne Mudhu, S., Loganathan, S. E., Kodavala, S., & Sarma, P. V. G. K. (2021). Increased insulin and GLUT2 gene expression and elevated glucokinase activity in β-like cells of islets of Langerhans differentiated from human haematopoietic stem cells on treatment with Costus igneus leaf extract. Molecular Biology Reports, 48.

P. V. G. K. Sarma has advanced translational biotechnology through pioneering stem cell differentiation, molecular genetics, and microbial pathogenesis research that directly supports regenerative medicine and precision diagnostics. His work bridges laboratory science with clinical and industrial applications, contributing to improved disease understanding, therapeutic development, and global biomedical innovation.

Dr. Mostafa Saberian | Biochemistry | Best Researcher Award

Dr. Mostafa Saberian | Biochemistry | Best Researcher Award

Lecturer | Tehran University of Medical Sciences | Iran

Prof. Mostafa Saberian is highly suitable for the Best Researcher Award, reflecting a distinguished career in medical laboratory sciences at Tehran University of Medical Sciences since 2009, with prior professional activity dating back to 2008. His research contributions encompass a diverse range of impactful studies, including molecular and clinical investigations on calcium channels in anesthesia, innovative hydrogel-based approaches for tissue engineering and wound healing, and regenerative medicine applications using mesenchymal stem cells. Notably, his work has been published in high-quality journals such as Molecular Pain, Tissue Engineering Part B: Reviews, Heliyon, and the Journal of Professional Nursing, demonstrating both breadth and depth in biomedical research. He has also made significant contributions to clinical studies, including investigations on fluid balance in post-operative acute kidney injury and the impact of probiotics and natural compounds on cellular proliferation, highlighting a translational focus bridging laboratory research and clinical applications. Beyond his publications, Prof. Saberian has actively engaged in peer review, contributing 33 reviews across seven prestigious journals, which underscores his commitment to advancing scientific rigor and supporting the broader research community. His interdisciplinary approach, combining molecular biology, tissue engineering, regenerative medicine, and clinical insights, reflects innovative thinking and a capacity to address complex biomedical challenges. Additionally, his collaboration with both national and international researchers emphasizes his ability to foster partnerships and contribute to global scientific discourse. Overall, Prof. Saberian’s sustained scholarly productivity, impactful research outputs, and dedication to mentoring and peer review make him a highly deserving candidate for the Best Researcher Award, recognizing not only his academic excellence but also his leadership and influential presence in advancing medical and biomedical sciences at both national and international levels.

Featured Publications

  1. Saberian, M., Shamsi, A., Mohseni, M. M., Taghizadehimani, A., & Shahidi Delshad, E. (2025). Calcium channels in anesthesia management: A molecular and clinical review. Molecular Pain.

  2. Molaei, R., Hosseinkhani, A., & Saberian, M. (2025). Molecular regulation of tissue remodeling through chitosan-based hydrogels in wound healing dynamics. Tissue Engineering Part B: Reviews.

  3. Saberian, M., Safari Roudsari, R., Haghshenas, N., Rousta, A., & Alizadeh, S. (2024). How the combination of alginate and chitosan can fabricate a hydrogel with favorable properties for wound healing. Heliyon.

  4. Saberian, M., Abak, N. (2024). Hydrogel-mediated delivery of platelet-derived exosomes: Innovations in tissue engineering. Heliyon.

  5. Shahidi Delshad, E., Nobahar, M., Raiesdana, N., Yarahmadi, S., & Saberian, M. (2023). Academic resilience, moral perfectionism, and self-compassion among undergraduate nursing students: A cross-sectional, multi-center study. Journal of Professional Nursing.

Ms. Shahrzad Manavi Nameghi | Biochemistry | Best Researcher Award

Ms. Shahrzad Manavi Nameghi | Biochemistry | Best Researcher Award

Researcher | Islamic Azad University Tehran Medical Sciences | Iran

Shahrzad Manavi Nameghi is an accomplished molecular genetics researcher from Tehran, Iran, recognized for her work in diabetes, cancer pathways, gene therapy, and stem cell research. She completed her M.Sc. in Molecular Biology-Genetics at Islamic Azad University, Tehran Medical Sciences in 2019, where her thesis focused on the relation between the GIPR gene and type 2 diabetes, following a B.Sc. in Cellular and Molecular Biology-Genetics from Shahid Bahonar University, Kerman in 2017. Professionally, she has served as a lab technician and R&D assistant at Khazar Lab, Tehran, and as a main lab technician at Mendel Medical Genetics Laboratory, contributing to projects involving DNA and RNA extraction, real-time PCR, pyro-sequencing, ARMS-PCR, MLPA-PCR, and other molecular techniques. She has also worked as a research assistant at the Endocrine and Metabolism Research Institute, gaining expertise in RFLP-PCR and sequencing analysis. Her research interests include molecular genetics, diabetes and cancer-related gene pathways, gene therapy, and stem cell therapy, and she is proficient in analytical techniques such as ELISA, fragment analysis, primer design, and basic R programming. Shahrzad has published multiple peer-reviewed articles in indexed journals including Gene Reports, Endocrine and Metabolic Science, and Regenerative Biology and Medicine, with a growing citation count of 15 and h-index of 2, and serves as an editor and peer reviewer for biomedical journals. She has presented her work at international conferences, including the IDF Congress in Korea and Brussels, and completed various certifications and workshops in peer review, manuscript preparation, laboratory techniques, and molecular biology. Her achievements, dedication to research, and involvement in scientific communities underscore her leadership potential and commitment to advancing biomedical science. For her significant contributions to molecular genetics, diabetes, and cancer research, and her active role in knowledge dissemination and mentorship, Shahrzad Manavi Nameghi is a highly deserving candidate for the Best Researcher Award.

Profiles: Google Scholar | ORCID | Scopus | LinkedIn | ResearchGate

Featured Publications

  1. Manavi Nameghi, S. (2024). Unraveling the molecular genetic basis of type 2 diabetes. Journal of Gene Reports. CiteScore: 3.3. Citations: 4. H-index: 2.

  2. Manavi Nameghi, S. (2024). Exploring the recent advancement and future prospects of personalized medicine in type 2 diabetes. Journal of Endocrine and Metabolic Science. CiteScore: 2.8.

  3. Manavi Nameghi, S. (2023). Cancer stem cells as a considerable barrier in anti-cancer treatments. Journal of Regenerative Biology and Medicine. CiteScore: 7.

  4. Manavi Nameghi, S. (2023). Association of GIPR gene variant on the risk of type 2 diabetes: A case control study. Journal of Endocrine and Metabolic Science. CiteScore: 2.8.

  5. Manavi Nameghi, S. (2022). Investigating the highlights of pluripotent stem cells in type 2 diabetes. Journal of Regenerative Biology and Medicine. CiteScore: 7.